1. Home
  2. NBIX

as 06-18-2024 9:30am EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Neurocrine Biosciences Inc is a research-based pharmaceutical company advancing drug candidates in the central nervous system and endocrine-related categories. The company's three late stage clinical programs are elagolix which is hormone releasing antagonist for women's health, opicapone which is an inhibitor for parkinson's patients, and ingrezza for tourette syndrome.

Founded: 1992 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 14.0B IPO Year: 1996
Target Price: $155.32 AVG Volume (30 days): 783.0K
Analyst Decision: Buy Number of Analysts: 23
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 3.65 EPS Growth: 498.36
52 Week Low/High: $93.02 - $148.37 Next Earning Date: 07-30-2024
Revenue: $1,982,000,000 Revenue Growth: 23.99%
Revenue Growth (this year): 20.03% Revenue Growth (next year): 15.23%

NBIX Daily Stock ML Predictions

Stock Insider Trading Activity of Neurocrine Biosciences Inc. (NBIX)

Name Ticker Relationship Date Transaction Cost Per Share Shares Total Value Securities Owned After Transaction(s) SEC Form 4
SHERWIN STEPHEN A NBIX Director May 29 '24 Sell $133.47 15,000 $2,002,009.50 26,504 SEC Form 4
SHERWIN STEPHEN A NBIX Director May 29 '24 Sell $133.46 25,000 $3,336,555.00 26,504 SEC Form 4
Norwalk Leslie V NBIX Director May 17 '24 Sell $141.82 1,106 $156,849.93 994 SEC Form 4
Sharp Shalini NBIX Director May 17 '24 Sell $141.90 1,106 $156,943.39 994 SEC Form 4
LYONS GARY A NBIX Director May 14 '24 Sell $135.63 12,500 $1,695,370.00 116,947 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer May 6 '24 Sell $140.55 273 $38,370.15 7,507 SEC Form 4
BENEVICH ERIC NBIX Chief Commercial Officer Apr 15 '24 Sell $133.36 7,231 $964,359.42 40,778 SEC Form 4
BENEVICH ERIC NBIX Chief Commercial Officer Apr 15 '24 Sell $133.36 12,587 $1,678,660.22 40,778 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer Mar 21 '24 Sell $145.06 5,000 $725,320.00 7,507 SEC Form 4
BENEVICH ERIC NBIX Chief Commercial Officer Mar 14 '24 Sell $139.38 5,479 $763,656.99 40,778 SEC Form 4
BENEVICH ERIC NBIX Chief Commercial Officer Mar 14 '24 Sell $139.38 69,521 $9,689,760.51 40,778 SEC Form 4
MORROW GEORGE J NBIX Director Mar 14 '24 Sell $139.42 20,000 $2,788,432.00 0 SEC Form 4
MORROW GEORGE J NBIX Director Mar 14 '24 Sell $139.41 20,000 $2,788,278.00 0 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer Mar 13 '24 Sell $140.14 3,000 $420,419.40 7,507 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer Feb 28 '24 Sell $135.64 2,500 $339,103.50 7,507 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer Feb 28 '24 Sell $134.62 2,500 $336,550.00 7,507 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer Feb 28 '24 Sell $136.00 1,544 $209,984.00 7,507 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer Feb 28 '24 Sell $135.51 273 $36,994.23 7,507 SEC Form 4
BENEVICH ERIC NBIX Chief Commercial Officer Feb 28 '24 Sell $134.69 53,143 $7,157,729.70 40,616 SEC Form 4
BENEVICH ERIC NBIX Chief Commercial Officer Feb 28 '24 Sell $134.69 21,857 $2,943,877.80 40,616 SEC Form 4
Norwalk Leslie V NBIX Director Feb 27 '24 Sell $135.67 8,000 $1,085,388.00 0 SEC Form 4
POPS RICHARD F NBIX Director Feb 20 '24 Sell $132.47 15,000 $1,987,047.00 29,512 SEC Form 4
Delaet Ingrid NBIX Chief Regulatory Officer Feb 13 '24 Sell $133.03 716 $95,252.77 7,507 SEC Form 4
ABERNETHY MATT NBIX Chief Financial Officer Feb 13 '24 Sell $132.85 1,352 $179,611.58 31,528 SEC Form 4
Lippoldt Darin NBIX Chief Legal Officer Feb 13 '24 Sell $132.99 1,098 $146,028.40 39,740 SEC Form 4

Share on Social Networks: